Pneumocystis carinii Pneumonia

2nd ed., revised and expanded. Lung Biology in Health Disease Series, Volume 69. Edited by PETER D. WALZER. xxvii + 744 pages, hardback, illustrated. Marcel Dekker, Inc., New York. 1993 Cost: $195

Thomas R. Navin Division of Parasitic Diseases, National Center for Infectious Diseases Centers for Disease Control and Prevention, 4770 Buford Highway NE Atlanta, Georgia

Search for other papers by Thomas R. Navin in
Current site
Google Scholar
Restricted access

Even with the availability of highly effective drugs that can prevent Pneumocystis carinii pneumonia (PCP), this infection continues to be the greatest single defining illness of acquired immunodeficiency syndrome (AIDS). Despite significant progress over the last decade in our knowledge about the diagnosis and treatment of this infection, the fact that so much of the basic biology and epidemiology of P. carinii remains unknown continues to be a source of frustration to scientists working with this parasite. Pneumocystis carinii Pneumonia, edited by Peter D. Walzer, M.D., Chief of the Infectious Diseases Section of the Cincinnati Veterans Affairs Medical Center, documents both the recent progress in our knowledge as well as the continued frustration (based principally on our inability to culture the organism) that this new knowledge has come so haltingly and at such high cost.

The volume contains 31 chapters written by leading authorities on PCP.

It is divided into six parts: basic biology, epidemiology, pathophysiology, clinical features, diagnosis, and treatment and prevention.